Brief: Hisamitsu Pharmaceutical Signs Agreement With Kyowa Hakko Kirin For Parkinson's Disease Treatment Hisamitsu Is Developing
05/02/2019 07:54
Feb 5 (Reuters) - Hisamitsu Pharmaceutical Co Inc 4530.T :
* SIGNED SALES AGREEMENT WITH KYOWA HAKKO KIRIN FOR
PARKINSON'S
DISEASE TREATMENT HISAMITSU IS DEVELOPING
* KYOWA HAKKO KIRIN WILL SELL ITS PARKINSON'S DISEASE
TREATMENT IN
JAPAN ONCE ITS APPLICATION IS APPROVED
* EXPECTS ITS APPLICATION FOR MANUFACTURE AND SALES WILL BE
APPROVED BY FEB 2020
Source text for Eikon: ID:nTSNE72dce
Further company coverage: 4530.T
(Reporting By Chris Gallagher)
((chris.gallagher@thomsonreuters.com;))
Recent news on Hisamitsu Pharmaceutical Co
See all newsTable: Hisamitsu -2025/26 group results
Table: Hisamitsu -2025/26 parent results
Brief: Hisamitsu Pharmaceutical Co Inc - To Retire Treasury Shares Worth 6.34% Of Outstanding Stock On May 12
Brief: Hisamitsu Pharmaceutical Co Inc - Tender Offer Of Company By Taiyo Kosan Successfully Completed
Japan's Hisamitsu Pharmaceutical plans $2.55 billion MBO